Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
about
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challengeAttenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive ratsHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepAnchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryIn vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.Pirfenidone treatment of idiopathic pulmonary fibrosis.Pirfenidone: an anti-fibrotic therapy for progressive kidney disease.Pirfenidone for diabetic nephropathy.Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy.Emerging drugs for idiopathic pulmonary fibrosis.Current and emerging drugs for idiopathic pulmonary fibrosis.Current and future anti-fibrotic therapies for chronic liver disease.Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARgamma agonist KR62776.Pirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro.Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis.Investigational approaches to therapies for idiopathic pulmonary fibrosis.Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration.Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine.Pharmacokinetics of orally administered pirfenidone in male and female beagles.Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers.The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.Pirfenidone exerts a suppressive effect on CCL18 expression in U937-derived macrophages partly by inhibiting STAT6 phosphorylation.
P2860
Q24652737-A7B25B0D-541A-47A5-9752-A5E0A9DDD335Q24673267-4E673E62-7BEE-46CD-908D-E1060C24686AQ26771518-02F785A1-6546-49E3-8CB8-BE65E4AE1E5DQ33894802-6FCC7867-40EE-479F-9051-5A222F002947Q34088175-D6D8E20E-74D7-4B2B-8627-5B7C14644A59Q34574174-B2299ACE-E78A-4571-A90A-1DE1504DE33EQ34680788-3A7E9D2A-5938-4B6B-A6DF-EC7287B3F529Q35012444-293A4433-C5DE-471C-84E7-7B518ECC60E8Q35841561-CA58902E-0996-4E85-BC65-7A344A1C56E6Q36302828-C3FE3540-29E1-4B2E-AF7D-1BEFF6B805F0Q36989934-E32DD4F0-4733-4D83-BB0F-4B611D6BAFF5Q37317654-C06C9C1F-95A7-40F5-8F48-CBC5D5BDE7CDQ37329375-9D5D5656-F924-4D19-8BD0-B7BEB20549ABQ37445130-72C0473A-4350-4D1F-AB77-5ADC2DA84B01Q37708036-7AD2053C-0671-411F-B4CF-D33D87D90C8FQ37742646-1B70FA13-2281-4700-97D8-909D77BDEDC1Q37762829-C3558974-0080-48BF-AC78-BE3B57C61E88Q44063009-F540B6D9-B414-439D-81C5-31A30DAA02BDQ44169303-F49E9501-D9C9-4C63-965A-8CA2ACBDE2C2Q45120795-81A047E5-40AA-40C5-89CF-A67FCC2566A1Q46974104-82700367-B620-4EDD-B107-4B011C93E7EBQ48933675-D757E99B-B076-4606-A95E-B9CBE03C83A5Q51359224-D00040E4-033F-44E5-BF98-1C1BDF0BC3E7
P2860
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@en
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@nl
type
label
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@en
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@nl
prefLabel
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@en
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@nl
P2093
P2860
P1476
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
@en
P2093
Nakamuta M
Nakashima Y
Sugimoto R
P2860
P304
P356
10.1046/J.1440-1681.2001.03481.X
P577
2001-07-01T00:00:00Z